Global Active Pharmaceutical Ingredients (API) Market at a CAGR of 6.50% During 2017 to 2024 | Data Bridge Market Research

The Global Active Pharmaceutical Ingredients (API) Market accounted to USD 155.1 billion in 2016 growing at a CAGR of 6.50% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2014, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global Active Pharmaceutical Ingredients (API) Market, By ProductType (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone), Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Request for Sample Report @

API is constantly increasing the outsourcing along with different methods of formulation of active drug ingredients due to the expiration of patent of branded drugs as a result there is no use of investing in R&D activities which can benefit the company or the manufacturers. Therefore manufacturers generally prefer generic drugs over the branded or recognized ones because of the growing sales in API market.

Active Pharmaceutical Ingredients (API) Market – Market Segmentation:

The Global Active Pharmaceutical Ingredients (API) Market,is segmented on the basis of type, manufacturer, synthesis, product,drug, therapy, and geography.


  • Innovative
  • Generic


  • Captive
  • Merchant


  • Synthetic
  • Biotech


  • mAb
  • Hormone

Browse Full Report with Details TOC @


  • OTC
  • Rx


  • Diabetes
  • Oncology
  • CNS
  • CVD

Active Pharmaceutical Ingredients (API)Market – Geographical Segmentation:

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Some of the major players operating in this market are

  • Teva Pharmaceutical Industries Ltd
  • Merck & Co., Inc
  • GlaxoSmithKline plc
  • Novartis International AG
  • Reddy’s Laboratories Ltd
  • AbbVie Inc
  • Bristol-Myers Squibb Company
  • Pfizer, Inc., Sanofi
  • Eli Lilly and Company
  • Boehringer Ingelheim
  • Sun Pharmaceutical Industries Limited
  • Aurobindo Pharma, Lupin
  • Albemarle Corporation,
  • Mylan N.V.,

Inquiry before Buying @

Active Pharmaceutical Ingredients (API) Market– Competitive Landscape:

The Active Pharmaceutical Ingredients (API) Market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market. The report also covers the market shares for global, North America, Europe, Asia-Pacific, Middle East and Africa and South Americaactive pharmaceutical ingredients (API) market.

Browse Related Reports:

Europe Active Pharmaceutical Ingredients (API) Market, By Product Type, By End-Use, By Distribution Channel, By Country (Germany, France, U.K., Spain, Italy, Russia, Turkey, Switzerland, Belgium, Netherlands, Rest of Europe) – Industry Trends and Forecast to 2024

About Data Bridge Market Research:                                                                              

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Ankit Singh

Data Bridge Market Research

Tel: +1-888-387-2818



Visit Blog

Follow us on LinkedIn:

Designed by
Powered by
%d bloggers like this: